Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I/II study is to investigate the safety and preliminary efficacy of
unilateral subretinal transplantation of HuCNS-SC cells in subjects with geographic atrophy
secondary to age-related macular degeneration.